Indivior withdraws key opioid dependency drug Sublocade from Australian market
US pharmaceutical company Indivior announced it will withdraw the life-saving opioid dependency drug Sublocade from the Australian market by December 31. This decision alarms health professionals, as the drug is seen as an effective alternative to daily treatments. The announcement follows AstraZeneca's recent decision to remove another critical medication, raising concerns about access to essential medicines.
How does this story land?
Summary by OZbrief Editorial · The Guardian Australia · Source
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
Published 01 Jul 2026, 07:55 UTC · Updated 01 Jul 2026, 08:20 UTC
Summary by OZbrief Editorial. Original report: The Guardian Australia. Editorial policy · Corrections
Trending
- 'It's who we are': Albanese issues impassioned defence of multiculturalism
- Katrina Kroetch showcases women's magic talent at Melbourne Magic Festival
- Adam Liaw’s brown sugar pudding
- Football-free zone: Wimbledon extends World Cup screening ban to players’ lounge
- Why Collingwood spent $4m on a South Melbourne property
- Aussie musicians vow to make voices heard in AI copyright war